Effect of Subcision and Suction on Acne Scars

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Murad Alam, Northwestern University
ClinicalTrials.gov Identifier:
First received: September 14, 2012
Last updated: February 11, 2016
Last verified: February 2016
The primary objective of this study is to determine whether the use of standard treatment in conjunction with suction will improve acne scars compared to a standard treatment alone.

Condition Intervention
Acne Scars
Procedure: Suction
Procedure: Subcision

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Pilot Split Face Randomized, Evaluator Blinded Study on the Effect of Subcision and Suctioning With a Microdermabrasion Device on Rolling Acne Scars

Resource links provided by NLM:

Further study details as provided by Northwestern University:

Primary Outcome Measures:
  • Change in acne scarring compared to baseline after treatments [ Time Frame: Baseline and 4 months ] [ Designated as safety issue: No ]
    The change in acne scarring is measured using a global scarring grading system to compare baseline scarring to the treatments.

Estimated Enrollment: 20
Study Start Date: September 2012
Estimated Study Completion Date: January 2017
Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Subcision & Suction
Standard treatment for acne scars followed by suction.
Procedure: Suction Procedure: Subcision
Active Comparator: Subcision
Standard treatment for acne scars only
Procedure: Subcision


Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Age 18 and over
  • Have bilateral rolling acne scars
  • Are in good health
  • Subject has the willingness and ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.

Exclusion Criteria:

  • Under 18 years of age
  • Pregnancy or lactation
  • Unable to understand the protocol or give informed consent
  • Has mental illness
  • Recent Accutane use in the past 6 months
  • Prone to hypertrophic and keloidal scarring
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01696513

United States, Illinois
Northwestern University Feinberg School of Medicine, Department of Dermatology
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Northwestern University
Principal Investigator: Murad Alam, MD Northwestern University
  More Information

Responsible Party: Murad Alam, Professor in Dermatology, Otolaryngology- Head and Neck Surgery, and Surgery-Organ Transplantation, Northwestern University
ClinicalTrials.gov Identifier: NCT01696513     History of Changes
Other Study ID Numbers: STU66710 
Study First Received: September 14, 2012
Last Updated: February 11, 2016
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on April 27, 2016